Increasing Russian Life Expectancy by 2030

25 May , 10:15–11:30
Harnessing Russia’s Growth Potential
Panel Session
Pavilion G, Conference Hall G4
In partnership with Abbott Laboratories

Making a breakthrough in life expectancy by increasing it from today's 73 to 78 by 2024 is a top priority for the Russian healthcare system. This challenge will require a huge concentration of effort by the whole of society: the state, business, and citizens themselves. An innovative development scenario for public health services should replace the current inert one. This means ensuring conditions in which healthcare professionals can practise creativity by choosing priorities, developing an effective programme with target indicators, making accurate and quick decisions, and establishing personal responsibility for the outcome. In order to achieve the goal of 78, the country must take immediate action. Should men and children be the priority focus of healthcare for the Russian population? What funding is required to reach 78 by 2024? Which strategic objectives should additional funding solve? How can the burden of responsibility for the population’s health be distributed between the state, employers, and citizens? What immediate solutions should be adopted in the healthcare system to meet the challenges of the time? How should doctors be trained to improve the level of trust between them and patients? Who should be appointed to manage healthcare in order to ensure significant improvements for the industry?

Guzel Ulumbekova, President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management

Kevin Ali, President, MSD International
Jan Olof Jacke, President, AstraZeneca AB
Andrew Lane, Executive Vice President, Abbott Laboratories
Siman Tov Moshe Bar, Director General, Ministry of Health of the State of Israel
Maxim Protasov, Head, Russian Quality System
Grigory Roytberg, Chief Executive Officer, Medicina
Aleksandr Rumyantsev, General Director, Dmitry Rogachev National Research Center
Veronika Skvortsova, Minister of Healthcare of the Russian Federation
Maxim Topilin, Minister of Labour and Social Protection of the Russian Federation
Vladimir Chekhonin, Vice President, Russian Academy of Sciences
Olivier Charmeil, Executive Vice President and General Manager, General Medicines and Emerging Markets, Sanofi

Front row participants
Elena Zhidkova, Head, Central Healthcare Directorate, Russian Railways
Nina Kandelaki, President, Chief Executive Officer, GE Healthcare Russia and CIS
Evgeniy Pokushalov, Deputy Director for Scientific and Experimental Work, Head of Intervention Cardiology Center, National Medical Research Center named after Academician E.N. Meshalkin of the Ministry of Health of the Russian Federation
Ekaterina Timofeeva, Partner, Managing Director, The Boston Consulting Group
Ayrat Farrakhov, Deputy, Member of the Committee on Budget and Taxes, State Duma of the Federal Assembly of the Russian Federation
Nyuta Federmesser, Head, Moscow Multidisciplinary Center for Palliative Care of the Moscow City Health Department
Taiji Tsukamoto, Chairperson, President, Sapporo Medical University
Viktor Cherepov, Executive Vice President, Russian Union of Industrialists and Entrepreneurs (RSPP)